SEARCH:   Advanced

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Nagai, Y. Articles by Miyake, K. Search for Related Content PubMed PubMed Citation Articles by Nagai, Y. Articles by Miyake, K. Related Collections Immunobiology Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 March 2002, Vol. 99, No. 5, pp. 1699-1705 IMMUNOBIOLOGY Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide Yoshinori Nagai, Rintaro Shimazu, Hirotaka Ogata, Sachiko Akashi, Katsuko Sudo, Hidetoshi Yamasaki, Shin-Ichi Hayashi, Yoichiro Iwakura, Masao Kimoto, and Kensuke Miyake From the Department of Immunology, Saga Medical School, Japan; the Center for Experimental Medicine, Division of Infectious Genetics, The Institute of Medical Science, The University of Tokyo, Japan; and the Department of Immunology, Faculty of Medicine, Tottori University, Yonago, Japan. RP105 is a B-cell surface molecule that has been recently assigned as CD180. RP105 ligation with an antibody induces B-cell activation in humans and mice, leading to proliferation and up-regulation of a costimulatory molecule, B7.2/CD86. RP105 is associated with an extracellular molecule, MD-1. RP105/MD-1 has structural similarity to Toll-like receptor 4 (TLR4)/MD-2. TLR4 signals a membrane constituent of Gram-negative bacteria, lipopolysaccharide (LPS). MD-2 is indispensable for TLR4-dependent LPS responses because cells expressing TLR4/MD-2, but not TLR4 alone, respond to LPS. RP105 also has a role in LPS responses because B cells lacking RP105 show hyporesponsiveness to LPS. Little is known, however, regarding whether MD-1 is important for RP105-dependent LPS responses, as MD-2 is for TLR4. To address the issue, we developed mice lacking MD-1 and generated monoclonal antibodies (mAbs) to the protein. MD-1-null mice showed impairment in LPS-induced B-cell proliferation, antibody production, and B7.2/CD86 up-regulation. These phenotypes are similar to those of RP105-null mice. The similarity was attributed to the absence of cell surface RP105 on MD-1-null B cells. MD-1 is indispensable for cell surface expression of RP105. A role for MD-1 in LPS responses was further studied with anti-mouse MD-1 mAbs. In contrast to highly mitogenic anti-RP105 mAbs, the mAbs to MD-1 were not mitogenic but antagonistic on LPS-induced B-cell proliferation and on B7.2 up-regulation. Collectively, MD-1 is important for RP105 with respect to B-cell surface expression and LPS recognition and signaling. © 2002 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: T. Kobayashi, K. Takahashi, Y. Nagai, T. Shibata, M. Otani, S. Izui, S. Akira, Y. Gotoh, H. Kiyono, and K. Miyake Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice Int. Immunol., July 1, 2008; 20(7): 881 - 891. [Abstract] [Full Text] [PDF] A. Meyer-Bahlburg, S. Khim, and D. J. Rawlings B cell intrinsic TLR signals amplify but are not required for humoral immunity J. Exp. Med., December 24, 2007; 204(13): 3095 - 3101. [Abstract] [Full Text] [PDF] S. Divanovic, A. Trompette, L. K. Petiniot, J. L. Allen, L. M. Flick, Y. Belkaid, R. Madan, J. J. Haky, and C. L. Karp Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105 J. Leukoc. Biol., August 1, 2007; 82(2): 265 - 271. [Abstract] [Full Text] [PDF] K. E. Gunn and J. W. Brewer Evidence That Marginal Zone B Cells Possess an Enhanced Secretory Apparatus and Exhibit Superior Secretory Activity J. Immunol., September 15, 2006; 177(6): 3791 - 3798. [Abstract] [Full Text] [PDF] Y. Wakabayashi, M. Kobayashi, S. Akashi-Takamura, N. Tanimura, K. Konno, K. Takahashi, T. Ishii, T. Mizutani, H. Iba, T. Kouro, et al. A Protein Associated with Toll-Like Receptor 4 (PRAT4A) Regulates Cell Surface Expression of TLR4 J. Immunol., August 1, 2006; 177(3): 1772 - 1779. [Abstract] [Full Text] [PDF] R. M Gorczynski, Y. Kai, and K. Miyake MD1 Expression Regulates Development of Regulatory T Cells J. Immunol., July 15, 2006; 177(2): 1078 - 1084. [Abstract] [Full Text] [PDF] S. Divanovic, A. Trompette, S. F. Atabani, R. Madan, D. T. Golenbock, A. Visintin, R. W. Finberg, A. Tarakhovsky, S. N. Vogel, Y. Belkaid, et al. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1 Innate Immunity, December 1, 2005; 11(6): 363 - 368. [Abstract] [PDF] J. Koraha, N. Tsuneyoshi, M. Kimoto, J.-F. Gauchat, H. Nakatake, and K. Fukudome Comparison of Lipopolysaccharide-Binding Functions of CD14 and MD-2 Clin. Vaccine Immunol., November 1, 2005; 12(11): 1292 - 1297. [Abstract] [Full Text] [PDF] W. A. Derbigny, M. S. Kerr, and R. M. Johnson Pattern Recognition Molecules Activated by Chlamydia muridarum Infection of Cloned Murine Oviduct Epithelial Cell Lines J. Immunol., November 1, 2005; 175(9): 6065 - 6075. [Abstract] [Full Text] [PDF] B. Hebeis, E. Vigorito, D. Kovesdi, and M. Turner Vav proteins are required for B-lymphocyte responses to LPS Blood, July 15, 2005; 106(2): 635 - 640. [Abstract] [Full Text] [PDF] Y. Nagai, T. Kobayashi, Y. Motoi, K. Ishiguro, S. Akashi, S.-i. Saitoh, Y. Kusumoto, T. Kaisho, S. Akira, M. Matsumoto, et al. The Radioprotective 105/MD-1 Complex Links TLR2 and TLR4/MD-2 in Antibody Response to Microbial Membranes J. Immunol., June 1, 2005; 174(11): 7043 - 7049. [Abstract] [Full Text] [PDF] I. B. Bekeredjian-Ding, M. Wagner, V. Hornung, T. Giese, M. Schnurr, S. Endres, and G. Hartmann Plasmacytoid Dendritic Cells Control TLR7 Sensitivity of Naive B Cells via Type I IFN J. Immunol., April 1, 2005; 174(7): 4043 - 4050. [Abstract] [Full Text] [PDF] N. Tsuneyoshi, K. Fukudome, J. Kohara, R. Tomimasu, J.-F. Gauchat, H. Nakatake, and M. Kimoto The Functional and Structural Properties of MD-2 Required for Lipopolysaccharide Binding Are Absent in MD-1 J. Immunol., January 1, 2005; 174(1): 340 - 344. [Abstract] [Full Text] [PDF] J. Pugin, S. Stern-Voeffray, B. Daubeuf, M. A. Matthay, G. Elson, and I. Dunn-Siegrist Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock Blood, December 15, 2004; 104(13): 4071 - 4079. [Abstract] [Full Text] [PDF] T. Fujimoto, S. Yamazaki, A. Eto-Kimura, K. Takeshige, and T. Muta The Amino-terminal Region of Toll-like Receptor 4 Is Essential for Binding to MD-2 and Receptor Translocation to the Cell Surface J. Biol. Chem., November 12, 2004; 279(46): 47431 - 47437. [Abstract] [Full Text] [PDF] M. Wagner, H. Poeck, B. Jahrsdoerfer, S. Rothenfusser, D. Prell, B. Bohle, E. Tuma, T. Giese, J. W. Ellwart, S. Endres, et al. IL-12p70-Dependent Th1 Induction by Human B Cells Requires Combined Activation with CD40 Ligand and CpG DNA J. Immunol., January 15, 2004; 172(2): 954 - 963. [Abstract] [Full Text] [PDF] T. L. Gioannini, A. Teghanemt, K. A. Zarember, and J. P. Weiss Regulation of interactions of endotoxin with host cells Innate Immunity, December 1, 2003; 9(6): 401 - 408. [Abstract] [PDF] G. Meng, A. Grabiec, M. Vallon, B. Ebe, S. Hampel, W. Bessler, H. Wagner, and C. J. Kirschning Cellular Recognition of Tri-/Di-palmitoylated Peptides Is Independent from a Domain Encompassing the N-terminal Seven Leucine-rich Repeat (LRR)/LRR-like Motifs of TLR2 J. Biol. Chem., October 10, 2003; 278(41): 39822 - 39829. [Abstract] [Full Text] [PDF] N. Yazawa, M. Fujimoto, S. Sato, K. Miyake, N. Asano, Y. Nagai, O. Takeuchi, K. Takeda, H. Okochi, S. Akira, et al. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes Blood, August 15, 2003; 102(4): 1374 - 1380. [Abstract] [Full Text] [PDF] T. Ichiba, T. Teshima, R. Kuick, D. E. Misek, C. Liu, Y. Takada, Y. Maeda, P. Reddy, D. L. Williams, S. M. Hanash, et al. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays Blood, July 15, 2003; 102(2): 763 - 771. [Abstract] [Full Text] [PDF] E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414. [Abstract] [Full Text] [PDF] A K Singh and Y Jiang Lipopolysaccharide (LPS) induced activation of the immune system in control rats and rats chronically exposed to a low level of the organothiophosphate insecticide, acephate Toxicology and Industrial Health, March 1, 2003; 19(2-6): 93 - 108. [Abstract] [PDF] K. Miyake, Y. Nagai, S. Akashi, M. Nagafuku, M. Ogata, and A. Kosugi Essential role of MD-2 in B-cell responses to lipopolysaccharide and Toll-like receptor 4 distribution Innate Immunity, December 1, 2002; 8(6): 449 - 452. [Abstract] [PDF]

	Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020